Locations

People Search

Filter
View All
Loading... Sorry, No results.
bscr
{{attorney.N}} {{attorney.R}}
{{attorney.O}}
Page {{currentPage + 1}} of {{totalPages}} [{{attorneys.length}} results]

loading trending trending Insights on baker sterchi

FILTER

Ready, Set, PREP! Applying PREP Act Immunity under Schmidt to Employment Claims—and Beyond.

ABSTRACT: Could the specific language of an FDA authorization for a COVID-19 test be the red light or green light for a hostile-work-environment claim? The answer, surprisingly, is yes. Employers should consider PREP Act immunity when assessing claims related in any way to COVID-19 or other major outbreaks.

In Schmidt v. City of Pasadena, the Ninth Circuit held that PREP Act immunity barred an employee’s claims against the City, including a hostile-work-environment claim. But what is the PREP Act, and how can it apply to employment-related claims?

The Public Readiness and Emergency Preparedness (“PREP”) Act is a 2005 federal statute providing immunity from “claims for loss” arising from actions taken to prevent the spread of disease. It is effective only during periods when the Secretary of Health and Human Services has made an emergency declaration placing the Act into effect. This occurred during the COVID-19 pandemic, when the Health Secretary made a number of declarations that have been in place from 2020 through the present. When the PREP Act is in effect, immunity applies to “covered persons” engaged in “covered countermeasures.” A covered person can be a governmental entity or a private person or business entity. Covered countermeasures are those that are enumerated within the Health Secretary’s declaration putting the Act into effect and authorized by the FDA. For example, and speaking broadly here, a clinic administering FDA-approved COVID-19 vaccines during the declaration-period of the COVID-19 pandemic would likely be immune from claims for loss under the PREP Act.

The Ninth Circuit’s decision in Schmidt focused on the breadth of the immunity provided by the PREP Act. An employee of the City of Pasadena used a religious exemption to opt out of vaccination during the COVID-19 pandemic. Because the employee had opted out of vaccination, the City instead required him to wear a mask at work and test for COVID-19.

After going through this regimen, the employee sued the City on several theories of liability including a hostile workplace because, he alleged, his masking and testing made known to other employees of the City that he had taken a religious exemption. The City moved to dismiss the employee’s complaint, and, after amendments to the complaint, obtained dismissal, in part because the employee had failed to allege a waiver of immunity under the PREP Act.

On appeal, the employee argued that the City had not engaged in a “covered countermeasure.” In ruling that the City’s masking and testing policies were “covered countermeasures,” the Ninth Circuit noted that the declarations of the Health Secretary are to be construed broadly. The employee argued that testing and masking were not authorized countermeasures because they were not proven to be effective. The Court analyzed the language of the FDA’s authorization for the specific type of test administered by the City. Even though the test had been proven effective for nasal swabs but not saliva samples, the authorization for the test was not written to exclude methods of testing beyond nasal swabbing. As for masking, the Court noted that masks were included as countermeasures to “prevent the spread” of COVID-19.

Notably, while the district court had dismissed only some of the employee’s claims due to PREP Act immunity, the Ninth Circuit went further and dismissed all of the employee’s claims based on such immunity. In doing so, the Ninth Circuit clarified that the PREP Act’s scope is not limited by cause of action and instead applies to any cause of action for which there is a “claim for loss” caused by a covered person administering a covered countermeasure. This holding is in line with the Tenth Circuit’s holding in Dressen v. AstraZeneca AB, 182 F.4th 1232 (10th Cir.), decided in July of this year. The holding is significant because it makes clear that PREP Act immunity applies to employment claims and other claims that may not immediately come to mind when considering immunity from actions taken to stop the spread of disease. As such, employers would do well to be aware of the Health Secretary’s declarations under the PREP Act and tailor their policies to conform to the contours of the declaration, when applicable, to minimize liability.